17 September 2024
Spire Healthcare Group plc (the "Company" or "Spire Healthcare")
Acquisition of Spire Healthcare shares by a Spire Healthcare Director
The following Spire Healthcare Director has purchased ordinary shares in the Company as follows:
| Director | Position | Shares purchased | Date of purchase | Price | Holding post announcement |
| Justin Ash | Chief Executive Officer | 21,100 | 17 September 2024 | 236.25 pence | 848,740 |
Enquiries:
Mantraraj Budhdev
Group General Counsel and Company Secretary
+44 7787 283848
Notification and public disclosure of transaction by persons discharging managerial responsibility and persons closely associated with them
| 1 | Details of the person discharging managerial responsibilities/person closely associated | ||
| a) | Name
| Justin Ash | |
| 2 | Reason for the notification | ||
| a) | Position/status
| Chief Executive Officer and Executive Director | |
| b) | Initial notification /Amendment
| Initial notification | |
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
| a) | Name
| Spire Healthcare Group plc | |
| b) | LEI | 213800IBJPW3SE2RA350 | |
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 1 pence each
GB00BNLPYF73 | |
| b) | Nature of the transaction | Purchase of 21,100 ordinary shares at 236.25 pence each | |
| c) | Price(s) and volume(s) | Price(s) | Volume(s) |
| 236.25 pence | 21,100 | ||
|
| |||
| d) | Aggregated information - Aggregated volume - Price | As above | |
| e) | Date of the transaction | 2024-09-17 | |
| f) | Place of the transaction | XLON | |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
